• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • T Regulatory Cell Therapies
      • SOD1 Therapies & Trials
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • Diagnostic Delay (in development)
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Meeting
    • Allied Professionals Forum
    • Alliance Webinars
    • ALS/MND Connect
    • Global Day Calendar
    • March of Faces
    • Patient Fellows Program
    • Global CRLI
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Alliance Webinars

Welcome to our webinar hub! Below, you’ll find a list of our upcoming and recorded webinars. Stay tuned as we add new webinars on a regular basis!


Bringing Voices for Life Across Borders

October 15, 2025 | 11 am – 12:15 pm ET

This webinar will take participants through an end-to-end demonstration of creating and using AI voice tools, highlighting the process from start to finish. The session will feature walkthroughs that illustrate how technology can be applied in different global contexts, complemented by testimonials to ground the experience in real-world impact.
 
We will showcase examples from different regions demonstrating both the universality and regional adaptability of the process.
 
Captions in multiple languages available.
 
REGISTER NOW

Annual Clinical Trials Update

November 5, 2025 | 8 am – 9:30 am ET
 
In this webinar, we will share the latest information on ALS/MND treatments currently in Phase 3 clinical trials. We will look at trial timelines, site locations, additional programs available, and key contacts for further information.
 
Moderators: Dr. Nadia Sethi & Dr. Martina de Majo
 
Captions in multiple languages available.
 
REGISTER NOW

2025 Recordings

SCIENTIFIC ADVISORY COUNCIL MID-YEAR UPDATE – This webinar provides a mid-year update from the Alliance’s Scientific Advisory Council (SAC). Participants also had the opportunity to ask the SAC questions about what is happening in ALS/MND research.

ALS/MND PLATFORM TRIALS UPDATE – This webinar provides information on ALS/MND platform trials. We hear from HEALEY, EXPERTS ALS and SMART. They update us on their approach, recruitment, trial eligibility and their latest news.


2024 Recordings

ANNUAL CLINICAL TRIALS UPDATE – This webinar provides information on ALS/MND treatments currently in Phase 3 clinical trials. We hear directly about timelines, where the sites are, other programs offered and whom to contact if more information is needed.

GLOBAL ALS/MND AWARENESS DAY – In honour of Global Day, we explore the impact of the Ice Bucket Challenge, how it raised the profile of the ALS/MND and led to significant advancements in care, advocacy and research. You hear from Nancy Frates, mother of Pete Frates, one of the individuals credited with starting the Ice Bucket Challenge, as well as member organizations about the impacts they’ve seen both locally and globally. Also, see the debut of our member Ice Bucket Challenge video, showcasing members participating in the challenge around the world to spread HOPE to every corner!

RESPIRATORY SUPPORT IN ALS/MND – This webinar covers the essentials to understand respiratory support in ALS/MND. We look at how breathing is affected, what care and support can be followed, non-invasive equipment available, as well as what is a tracheostomy, how it works, and considerations.

MENTAL HEALTH IN ALS/MND – This webinar provides tools and recommendations for people living with ALS/MND, their caregivers and youth. We learn how to take care of our mental health upon diagnosis, how to deal with our emotions like guilt and anxiety, and how to drive motivation and other activities that will provide happiness and enjoyment.

ALS/MND PLATFORM TRIALS UPDATE – This webinar provides information on ALS/MND platform trials. We hear from HEALEY, MAGNET and SMART representatives who update us on their approach, recruitment, trial eligibility and their latest news.

NUTRITION IN ALS/MND – This webinar provides an understanding of the importance of nutrition in ALS/MND. We address nutritional changes upon diagnosis, considerations for bulbar onset ALS/MND, and the myths and benefits of feeding tubes.

ANNUAL GLOBAL CLINICAL TRIALS UPDATE – This webinar provides information on ALS/MND treatments currently in Clinical Trials. We hear directly about timelines, where the sites are, other programs offered and who to contact if more information is needed.

2023 Recordings

MENTAL HEALTH SUPPORT FOR PEOPLE LIVING WITH ALS/MND and CAREGIVERS– Join us in this webinar where our expert panel delves into the emotional impact experienced by people with ALS/MND, caregivers, young adults, and children. We will look at the challenges of coping with the progressive changes ALS/MND brings, processing loss, and other key considerations to maintain mental health. Prof. Melinda Kavanaugh – Global Neuro YCare, Dr. John Ashworth – North Bristol NKS Trust, Albert Koo – Malaysia. Moderated by: Marcela Santos – Colombian ALS/MND Association (ACELA)

GLOBAL FUNDAMENTAL RIGHTS SURVEY RESULTS – The International Alliance of ALS/MND Associations surveyed the community about the Fundamental Rights of People living with ALS/MND and Caregivers. Learn more about the data, strengths and weaknesses at a global level, the questions raised, the topics that require further attention, and how these compared to our 2021 survey.

SCIENTIFIC ADVISORY COUNCIL UPDATE & Q&A – Join us for the mid-year update from the Scientific Advisory Council. Dr. Nicholas Cole – MND Association Dr. Kuldip Dave – The ALS Association Dr. Nadia Sethi – ALS Therapy Development Institute Dr. David Taylor – ALS Canada Moderated by: Dr. Gethin Thomas – MND Australia 

MAINTAINING MY INDEPENDENCE – Watch our webinar with occupational therapist Sarah Solomon and Gudjon Sigurdsson, a person living with ALS/MND. They  provide recommendations on how to maintain independence when living with this diagnosis. Moderated by Sara Feldman.  

GENETIC COUNSELING AND TESTING – Familial or sporadic ALS/MND, the importance of genetic counselling and testing can´t be emphasized enough. Join us for this scenario-based discussion which will look at real situations ranging from an ALS/MND asymptomatic carrier to someone whose parent had ALS/MND, but has not done genetic testing.

SHARING SUCCESS: A FIRESIDE CHAT WITH THE 2022 AWARD WINNERS – An informal conversation with the 2022 Award winners on their careers and their contributions to the field of ALS/MND. Panelists include Sally Light (Humanitarian Award recipient), Dr. Richard Bedlack (Forbes Norris Award recipient), and Richard Cave (Allied Health Professional Award recipient). *English and Spanish captions available.

WHAT DO I NEED TO KNOW ABOUT CLINICAL TRIALS?– Learn about the importance of clinical trials, how to find a suitable clinical trial, and what to consider if you want to take part and next steps. Moderated by Rachael Marsden. Panelists include Allison Bulat, Nadia Sethi & Paula Trefiak. *English and Spanish captions available.

2022 Recordings

FIRST ANNUAL GLOBAL CLINICAL TRIALS UPDATE – This webinar provides information on ALS/MND treatments currently in Phase 3 Clinical Trials. We heard directly about timelines, where the sites are, other programs offered, and who to contact if more information is needed. Moderated by Gethin Thomas, Executive Director, Research – MND Australia, and Dr. Thanuja Dharmadasa, Senior Clinical Research Fellow at The Royal Melbourne Hospital and The Florey Institute of Neuroscience and Mental Health in Victoria, Australia. Enjoy presentations from AB Science, Amylyx, Biogen, Clene Nanomedicine, Cytokinetics, Ferrer, Ionis, and Mitsubishi Tanabe Pharma!

GENETIC COUNSELLING – Join us in learning more about genetic counselling in ALS/MND. Genetic counsellor Ashley Crook will be providing us with an overview of genetic counselling, different types of genetic testing, and genetic counselling considerations before testing.

VOICE BANKING – In this webinar we will learn more about the new assistive technology of voice banking.  . We will cover basic concepts, how it is done, timing, considerations and limitations. Moderator: Sara Feldman – ALS Hope Foundation. Panel: Alicia Gibb – MND New South Wales, Monique Signorelli – Motor Neurone Disease (MND) Clinic  – Communication and Assistive Technology (CAT) Clinic, Emily Kornman – Team Gleason, and Norman MacIsaac -PALS Perspective.

INNOVATION IN CLINICAL TRIAL DESIGN – Clinical trial design is evolving in the ALS/MND community.  This webinar updates us on what the new models are, how they are changing the landscape and what are the practical implications for our community. Moderators: Gethin Thomas  – Executive Director, Research | Motor Neurone Disease Australia & Claire Magnussen, PhD – Program Manager | CAPTURE ALS, McGill University. Panel: Dr. Merit Cudkowicz  – HEALEY Trial, Dr. Ruben van Eijk – MAGNET Trial, Dr Suvankar Pal & Professor Siddharthan Chandran – SMART Trial.

APP DEMONSTRATION – We demonstrate applications that can help people living with ALS/MND with their communication. Panel includes: Alper Kaya (Co-Chair of the Turkish ALS/MND Association & Person living with ALS/MND and Richard Cave (Speech and Language Therapist & Project Manager for MND Association).

SCIENTIFIC ADVISORY COUNCIL UPDATE & Q&A – Mid-year update from the Alliance’s Scientific Advisory Council.

CARE PART 3: END OF LIFE – This is not an easy topic, but one that is important to discuss. In this webinar we provided guidance on how PALS and CALS can address this stage of their journey, and what to look for in support and planning resources.

CARE PART 2: WHAT ARE MY ONGOING NEEDS WITH ALS/MND? – This webinar addressed the questions: As ALS/MND progresses what are the ongoing needs of both people living with ALS/MND and their caregivers? And, how can those needs best be met? Moderated by Nick Goldup, Director of Care Improvement at MNDA UK.

CARE PART 1: WHAT DO I NEED TO KNOW AT DIAGNOSIS? – In this webinar we explored the steps and actions people living with ALS/MND and their caregivers should consider at diagnosis to move forward in their ALS/MND journey.

2021 GLOBAL SURVEY RESULTS – The International Alliance of ALS/MND Associations surveyed the community about the Fundamental Rights of People living with ALS/MND and Caregivers. Learn more about the data, strengths and weaknesses at a global level, the questions raised and the topics that require further attention.

SHARING SUCCESS: A FIRESIDE CHAT WITH THE 2021 AWARD WINNERS – An informal conversation with the 2021 Award winners on their careers, and their contributions to the field of ALS/MND.

2021 Recordings

ETHICAL CONSIDERATIONS FOR GENETICS– A discussion of the risks and benefits of genetic testing in individuals who are symptomatic or have a family history of ALS. Different contexts and potential considerations for individuals who are symptomatic for ALS, with and without a family history of ALS, or those who are asymptomatic for ALS but considering undergoing genetic testing will be discussed

GENETICS – COUNSELLING & TESTING – This webinar touches on; what is genetic counselling and role of a genetic counsellor, what is involved in genetics counselling & testing, availability, awareness of ethical issues surrounding genetic testing, psychological effects of genetic testing and tackling difficult concepts in ALS/MND clinical genetics. Click here for information on our Moderators & Presenters.

INTRODUCTION TO ALS/MND GENETICS – This webinar provides an overview of the current ALS/MND landscape and an understanding of genetics, so that people impacted by ALS/MND and their families have the basic tools to understand what this means and their options. Click here for information on our Moderators & Presenters.

OPTIMIZING CLINICAL TRIAL DESIGN – From outcome measures to entry criteria, this webinar explores the lessons we have learned from the failed trials of the past, and how those have been integrated in to our optimization of clinical trials of the future.

YOUTH AND ALS/MND– This webinar discusses the experience of a child whose parent has ALS/MND, and communication with a child to address their concerns and questions.

INNOVATION AND TECHNOLOGY IN ALS/MND – This webinar explores several student projects that were part of the ‘Accessibility and Assistive Technologies’ module at University College London. Each project focused on the design of technologies for people living with ALS/MND that helps bridge the gap between the capabilities of the person and those required to conduct a task. “Until there is a cure, technology is the cure”.

BIOMARKERS IN ALS/MND – This webinar provides an overview of biomarkers emerging as the front runners for the field, and how a combinatorial approach will likely be needed.

TELEMEDICINE BEST PRACTICES IN CARE & RESEARCH – This webinar discusses best practices in telemedicine, for both care and research, for patients living with ALS/MND.

Q&A WITH THE ALLIANCE’S SCIENTIFIC ADVISORY COUNCIL  – A mid-year update of the Alliance’s Scientific Advisory Council in honour of Global ALS/MND Awareness Day.

Primary Sidebar

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

  • Antonio Ventriglia,  ALS Liga Belgium,  Diagnosed 2013

    Antonio Ventriglia, ALS Liga Belgium, Diagnosed 2013

  • Frank "Papa" Taylor, USA

    Frank “Papa” Taylor, USA

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Sam Hayden-Harler, Motor Neurone Disease (MND) Association, UK

    Sam Hayden-Harler, Motor Neurone Disease (MND) Association, UK

  • Willi Klein

    Willi Klein

  • Shay Rishoni, Diagnosed 2011 , Prize4Life, Israel

    Shay Rishoni, Diagnosed 2011 , Prize4Life, Israel

  • John and Loretta Russo, USA

    John and Loretta Russo, USA
    final3878

  • Dorette Lüdi, Diagnosed 2014 , ALS Schweiz, Switzerland

    Dorette Lüdi, Diagnosed 2014 , ALS Schweiz, Switzerland

  • 83

    83

  • Margreth Burger-Saile, Diagnosed 2011,  ALS Schweiz,  Switzerland

    Margreth Burger-Saile, Diagnosed 2011, ALS Schweiz, Switzerland

  • Lombana, Spain

    Lombana, Spain

  • Shay Rishoni

    Shay Rishoni

  • Ana Lilia RodriguezApoyo Integral Gila A.C., Diagnosed 2018, Mexico

    Ana Lilia RodriguezApoyo Integral Gila A.C., Diagnosed 2018, Mexico

  • Ada Garrido Benavidez, Diagnosed 2016,  FYADENMAC, Mexico

    Ada Garrido Benavidez, Diagnosed 2016, FYADENMAC, Mexico

  • Frank "Papa" Taylor

    Frank “Papa” Taylor

  • John Dinon, MND Australia

    John Dinon, MND Australia

  • Liong Ting Ngu, MND Malaysia, Diagnosed 2014

    Liong Ting Ngu, MND Malaysia, Diagnosed 2014

  • Michael Lee, Australia

    Michael Lee, Australia

  • Chen Chun-Chin

    Chen Chun-Chin

  • Armando González Gómez, ACELA, Colombia

    Armando González Gómez, ACELA, Colombia

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Charlie “Hark” Dourney, Diagnosed 2007 , Hark ALS, USA

    Charlie “Hark” Dourney, Diagnosed 2007 , Hark ALS, USA

  • Peng Yi-Wen

    Peng Yi-Wen

  • Andrietta

    Andrietta

  • Orlando Ruiz, Diagnosed 2001,  ACELA, Colombia

    Orlando Ruiz, Diagnosed 2001, ACELA, Colombia

  • Chris McCauley, Diagnosed 2015 , ALS Canada

    Chris McCauley, Diagnosed 2015 , ALS Canada

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Soledad Rodriguez, FUNDELA, Diagnosed 2013, Spain

    Soledad Rodriguez, FUNDELA, Diagnosed 2013, Spain

  • Verónica Isabel Castro Molina, Diagnosed 2014, Argentina

    Verónica Isabel Castro Molina, Diagnosed 2014, Argentina

  • Alejandro Aquino, Diagnosed 2011 , Asociación ELA Argentina

    Alejandro Aquino, Diagnosed 2011 , Asociación ELA Argentina

  • Bob Simonds and Drew O'Neill , Les Turner ALS Foundation, USA

    Bob Simonds and Drew O’Neill , Les Turner ALS Foundation, USA

  • Dad

    Dad

  • Glen Elison,  ALS Hope Foundation,  Diagnosed 2019,  USA

    Glen Elison, ALS Hope Foundation, Diagnosed 2019, USA

  • Tammy Moore and Eddy Lefrancois

    Tammy Moore and Eddy Lefrancois

  • Bob Simonds and Drew O'Neil, USA

    Bob Simonds and Drew O’Neil, USA

  • Osiel Mendoza, Diagnosed 2016 ,  ALS Therapy Development Institute, USA

    Osiel Mendoza, Diagnosed 2016 , ALS Therapy Development Institute, USA

  • Xian-Zhang Niu, Diagnosed 2006 , Shaanxi ALS Association, China

    Xian-Zhang Niu, Diagnosed 2006 , Shaanxi ALS Association, China

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Zabun Nassar, MND Association, Diagnosed 2016, England

    Zabun Nassar, MND Association, Diagnosed 2016, England

  • Yolanda Armendariz, Diagnosed 2017 , FYADENMAC, Mexico

    Yolanda Armendariz, Diagnosed 2017 , FYADENMAC, Mexico

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Dick Dayton, USA

    Dick Dayton, USA

  • Kirsten Harley,  Diagnosed 2013,  Australia

    Kirsten Harley, Diagnosed 2013, Australia

  • Jason Goodman, Les Turner ALS Foundation, USA

    Jason Goodman, Les Turner ALS Foundation, USA

  • Ian and Teresa Roberts

    Ian and Teresa Roberts

  • Brigitte Wernli,  Association ALS Switzerland,  Diagnosed 2014

    Brigitte Wernli, Association ALS Switzerland, Diagnosed 2014

  • Inta Grubb, Diagnosed 2014,  MND Australia

    Inta Grubb, Diagnosed 2014, MND Australia

  • Jon Newsome, USA

    Jon Newsome, USA

  • Enzo Maccarrone, AISLA ONLUS, Italy

    Enzo Maccarrone, AISLA ONLUS, Italy

  • Richard Clark, MND New Zealand,  Diagnosed 2011

    Richard Clark, MND New Zealand, Diagnosed 2011

Learn more about the March of Faces

Latest Tweets

  • Just now

Footer

Subscribe to our Bi-Monthly Newsletter

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2025 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login